Benefit of Changing Chemoradiotherapy Sequence and Modifying Radiotherapy Schedule for Advanced Nasopharyngeal Cancer

NCT00577057 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

798

Enrollment

OTHER_GOV

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

PROCEDURE: Conventional Radiotherapy
PROCEDURE: Accelerated Radiotherapy
DRUG: Cisplatin
DRUG: 5-fluorouracil
DRUG: Capecitabine

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]